Soluble ST2: a valuable prognostic marker in heart failure
Sugeevan Savarimuthua b✉, Pavan Goelc, Amer Harkyd
- aDepartment of Medicine, Basildon Hospital, Basildon, UK. Sugeevan.savarimuthu@hotmail.com
- bDepartment of Medicine, Basildon Hospital, Basildon, UK
- cDepartment of Pharmacy, Liverpool Heart and Chest Hospital, Liverpool, UK
- dDepartment of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Natriuretic peptides have been at the forefront of biomarker use in heart disease and have been universally recommended as the ideal biomarker in the setting of heart failure. Soluble ST2 is one such biomarker which has found value as a prognostic marker and can be used individually or along with natriuretic peptides in order to prognosticate patients with heart failure. Leading cardiovascular organisations have recognised this biomarker, though its role as a diagnostic marker is yet to be determined. We aim to investigate the role of sST2 in heart failure in the existing literature.
TL;DRThis work aims to investigate the role of sST2 in heart failure in the existing literature and to establish its role as a diagnostic marker in the setting of heart failure. (Semantic Scholar)